X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (39) 39
index medicus (39) 39
chemistry (31) 31
metallurgy (28) 28
female (21) 21
human necessities (21) 21
male (21) 21
microbiology (20) 20
middle aged (18) 18
adult (17) 17
biochemistry (15) 15
beer (14) 14
compositions thereof (14) 14
culture media (14) 14
enzymology (14) 14
microorganisms or enzymes (14) 14
mutation or genetic engineering (14) 14
propagating, preserving or maintaining microorganisms (14) 14
spirits (14) 14
vinegar (14) 14
wine (14) 14
aged (13) 13
analysis (13) 13
physics (13) 13
drug resistance (11) 11
clinical trials (10) 10
tuberculosis (10) 10
young adult (10) 10
abridged index medicus (9) 9
adolescent (9) 9
care and treatment (9) 9
infectious diseases (9) 9
patients (9) 9
processes using microorganisms (9) 9
prospective studies (9) 9
treatment of water, waste water, sewage, or sludge (9) 9
double-blind method (8) 8
medicine, general & internal (8) 8
performing operations (8) 8
research (8) 8
studies (8) 8
transporting (8) 8
treatment outcome (8) 8
antitubercular agents - therapeutic use (7) 7
drug therapy (7) 7
grinding (7) 7
investigating or analysing materials by determining theirchemical or physical properties (7) 7
measuring (7) 7
polishing (7) 7
risk factors (7) 7
safety (7) 7
testing (7) 7
tools for grinding, buffing, or sharpening (7) 7
disease control (6) 6
electricity (6) 6
forestry (6) 6
immunology (6) 6
medicine (6) 6
microbial sensitivity tests (6) 6
mycobacterium tuberculosis - drug effects (6) 6
organic chemistry (6) 6
osteoporosis (6) 6
population (6) 6
research article (6) 6
russia (6) 6
tuberculosis, multidrug-resistant - drug therapy (6) 6
agriculture (5) 5
animal husbandry (5) 5
antibiotics (5) 5
diagnosis (5) 5
drug dosages (5) 5
drugs (5) 5
fishing (5) 5
foods or foodstuffs (5) 5
hunting (5) 5
hygiene (5) 5
incidence (5) 5
medical or veterinary science (5) 5
mortality (5) 5
prevalence (5) 5
risk (5) 5
russia - epidemiology (5) 5
semiconductor devices (5) 5
sputum - microbiology (5) 5
their treatment, not covered by other classes (5) 5
trapping (5) 5
tumor necrosis factor-tnf (5) 5
usage (5) 5
amusements (4) 4
animal and vegetable oils, fats, fatty substances and waxes (4) 4
antitubercular agents (4) 4
apparatus for physical training, gymnastics, swimming,climbing, or fencing (4) 4
arthritis (4) 4
article (4) 4
ball games (4) 4
basic electric elements (4) 4
biocides, e.g. as disinfectants, as pesticides, as herbicides (4) 4
biological activity (4) 4
candles (4) 4
cardiovascular disease (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Hernandez, Adrian F and Green, Jennifer B and Janmohamed, Salim and D'Agostino, Ralph B and Granger, Christopher B and Jones, Nigel P and Leiter, Lawrence A and Rosenberg, Anne E and Sigmon, Kristina N and Somerville, Matthew C and Thorpe, Karl M and McMurray, John J V and Del Prato, Stefano and Del Prato, Stefano and McMurray, John J.V and D'Agostino, Ralph B and Granger, Christopher B and Hernandez, Adrian F and Janmohamed, Salim and Leiter, Lawrence A and Califf, Robert M and Holman, Rury and DeMets, David and Riddle, Matthew and Goodman, Shaun and McGuire, Darren and Alexander, Karen and Devore, Adam and Melloni, Chiara and Patel, Chetan and Kong, David and Bloomfield, Gerald and Roe, Matthew and Tricoci, Pierluigi and Harrison, Rob and Lopes, Renato and Mathews, Robin and Mehta, Rajendra and Schuyler Jones, William and Vemulapalli, Sreekanth and Povsic, Thomas and Eapen, Zubin and Dombrowski, Keith and Kolls, Brad and Jordan, Dedrick and Ambrosy, Andrew and Greene, Stephen and Mandawat, Aditya and Shavadia, Jay and Cooper, Lauren and Sharma, Abhinav and Guimaraes, Patricia and Friedman, Daniel and Wilson, Matt and Endsley, Patricia and Gentry, Tracy and Collier, Jeannie and Perez, Kathleen and James, Kourtnei and Roush, Jennifer and Pope, Connie and Howell, Christina and Johnson, Megan and Bailey, Matt and Cole, Joanna and Akers, Teresa and Vandyne, Beth and Thomas, Betsy and Rich, Jenny and Bartone, Susan and Beaulieu, Gail and Brown, Kim and Chau, Tuan and Christian, Tamra and Coker, Rebecca and Greene, Deb and Haddock, Trevorlyn and Jenkins, Wendy and Haque, Ghazala and Marquess, Marsha and Pesarchick, Jean and Rethaford, Renee and Stone, Allegra and Al Kawas, Firas and Anderson, Michelle and Enns, Robert and Sinay, Isaac and Mathieu, Chantal and Yordanov, Victor and Hramiak, Irene and Haluzik, Martin and Galatius, Søren and Guerci, Bruno and Nauck, Michael and Migdalis, Ilias and Tan, Choon Beng Kathryn and Kocsis, Gyozo and Giaccari, Andrea and Lee, Moon Kyu and Muñoz, Ernesto German Cardona and ... and Harmony Outcomes committees and investigators and Harmony Outcomes Comm Investigator
The Lancet, ISSN 0140-6736, 10/2018, Volume 392, Issue 10157, pp. 1519 - 1529
Glucagon-like peptide 1 receptor agonists differ in chemical structure, duration of action, and in their effects on clinical outcomes. The cardiovascular... 
MEDICINE, GENERAL & INTERNAL | RISK | METAANALYSIS | MELLITUS | SAFETY | RECEPTOR AGONISTS | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Stroke - prevention & control | Double-Blind Method | Drug Administration Schedule | Glucagon-Like Peptide 1 - administration & dosage | Glucagon-Like Peptide 1 - analogs & derivatives | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Treatment Outcome | Stroke - etiology | Hypoglycemic Agents - administration & dosage | Injections, Subcutaneous | Adult | Female | Aged | Myocardial Infarction - prevention & control | Diabetes Mellitus, Type 2 - drug therapy | Myocardial Infarction - etiology | Diabetes Mellitus, Type 2 - complications | Glucagon-Like Peptide 1 - therapeutic use | Myocardial infarction | Diabetic retinopathy | Heart attacks | Peptides | Glucagon | Medical services | Clinical trials | Cardiovascular disease | Thyroid gland | Incidence | Thyroid carcinoma | Randomization | Motivation | Hemoglobin | Diuretics | Diabetes mellitus (non-insulin dependent) | Glucagon-like peptide 1 | Thyroid | Cerebral infarction | Stroke | Diabetes mellitus | Pancreatitis | Health risks | Risk reduction | Disease control | Patients | Organic chemistry | Interactive systems | Pancreatic cancer | Fatalities | Infarction | Diabetes | Cardiovascular diseases | Health risk assessment
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 390, Issue 10093, pp. 457 - 468
Summary Background Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis. The Oral Rheumatoid Arthritis triaL (ORAL) Strategy... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | MODIFYING ANTIRHEUMATIC DRUGS | NECROSIS-FACTOR | PLACEBO | JANUS KINASE INHIBITOR | INADEQUATE RESPONSE | LONG-TERM SAFETY | PLUS METHOTREXATE | AMERICAN-COLLEGE | OPEN-LABEL | COMBINATION | Antirheumatic Agents - administration & dosage | Humans | Middle Aged | Male | Methotrexate - therapeutic use | Adalimumab - adverse effects | Arthritis, Rheumatoid - drug therapy | Pyrroles - administration & dosage | Antirheumatic Agents - adverse effects | Pyrroles - adverse effects | Adult | Female | Drug Therapy, Combination | Pyrroles - therapeutic use | Antirheumatic Agents - therapeutic use | Severity of Illness Index | Piperidines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Administration, Oral | Pyrimidines - administration & dosage | Treatment Outcome | Methotrexate - adverse effects | Adalimumab - therapeutic use | Adalimumab - administration & dosage | Piperidines - therapeutic use | Pyrimidines - therapeutic use | Piperidines - adverse effects | Pyrimidines - adverse effects | Methotrexate - administration & dosage | Rheumatoid factor | Care and treatment | Analysis | Clinical trials | Arthritis | Pharmaceutical industry | Methotrexate | Rheumatology | Patients | Evidence-based medicine | Studies | Rheumatoid arthritis | Monoclonal antibodies | Rheumatism | TNF inhibitors | Janus kinase | Tumor necrosis factor-TNF | Safety | Drug therapy | Drug dosages
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2017, Volume 17, Issue 7, pp. 707 - 715
Journal Article
Osteoporosis and Bone Diseases, ISSN 2072-2680, 04/2018, Volume 21, Issue 1, pp. 17 - 22
Modern medications for osteoporosis (bisphosphonates, denosumab, teriparatide) are well-tolerated drugs, which can significantly lower vertebral and... 
bisphosphonates | expert opinion | osteoporosis | denosumab | bone fracture
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2015, Volume 373, Issue 26, pp. 2534 - 2548
Journal Article
Quality of Life Research, ISSN 0962-9343, 3/2018, Volume 27, Issue 3, pp. 707 - 716
Journal Article
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, ISSN 1942-0900, 2019, Volume 2019, pp. 4398695 - 13
Oxidative stress is a major issue in a wide number of pathologies (neurodegenerative, cardiovascular, immune diseases, and cancer). Because of this, the search... 
OXIDATIVE STRESS | PATHWAY | DNA-DAMAGE | ROS | DISEASE | MECHANISMS | CYTOTOXICITY | CELL BIOLOGY | Flow cytometry | Oxidative stress | Immunoglobulins | Disease | DNA damage | Cyclin-dependent kinases | Gene expression | Kinases | Carbon | Investigations | Antioxidants | Microscopy | Cell cycle | Fibroblasts | Fullerenes | Physiology | Mutation | Deoxyribonucleic acid--DNA
Journal Article
The Education and science journal, ISSN 1994-5639, 01/2016, Issue 5, pp. 176 - 188
Journal Article
Journal Article